Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NEUROINFLAMMATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
NEUROINFLAMMATION is a phenotype associated with neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with AD, ALS, ALZHEIMER. Connected to 2614 entities in the SciDEX knowledge graph.
No AI portrait yet
Knowledge base pages for this entity
graph TD
subgraph Signaling["Signaling"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| NEURODEGENERATION["NEURODEGENERATION"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Als["Als"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Neuroinflammation_1["Neuroinflammation"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Inflammation_2["Inflammation"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Autophagy["Autophagy"]
CYTOKINES["CYTOKINES"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
MITOCHONDRIAL_DYSFUNCTION["MITOCHONDRIAL DYSFUNCTION"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
end
subgraph Pathology["Pathology"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| NEURON["NEURON"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| TAU["TAU"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| Neuroinflammation["Neuroinflammation"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| Inflammation["Inflammation"]
APOE["APOE"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
MICROGLIA["MICROGLIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
APP["APP"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
MITOCHONDRIA["MITOCHONDRIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
end
style NEUROINFLAMMATION fill:#5d4400,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style NEURODEGENERATION fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style TAU fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Neuroinflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Neuroinflammation_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Inflammation_2 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APOE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MITOCHONDRIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MITOCHONDRIAL_DYSFUNCTION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Neurodegeneration | therapeutic_target | disease | 1.00 |
| Multiple Sclerosis | therapeutic_target | disease | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| Neuroinflammation | regulates | disease | 1.00 |
| Stroke | therapeutic_target | disease | 1.00 |
| Oxidative Stress | therapeutic_target | pathway | 1.00 |
| Parkinson | regulates | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Immune Response | therapeutic_target | pathway | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| Synaptic Plasticity | activates | pathway | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| Neuroinflammation | interacts_with | disease | 1.00 |
| Inflammation | interacts_with | disease | 1.00 |
| Stroke | regulates | disease | 1.00 |
| Neuroinflammation | therapeutic_target | disease | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Als | inhibits | disease | 1.00 |
| Nf-Κb | activates | pathway | 1.00 |
| Aging | activates | disease | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| Immune Response | therapeutic_target | pathway | 1.00 |
| Mtor | activates | pathway | 1.00 |
| Parkinson | activates | disease | 1.00 |
| Neuroinflammation | inhibits | disease | 1.00 |
| Phagocytosis | activates | pathway | 1.00 |
| Mapk | activates | pathway | 1.00 |
| NEURON | associated_with | gene | 1.00 |
| Mtor | activates | pathway | 1.00 |
| neurodegeneration | causes | phenotype | 1.00 |
| Nf-Κb | inhibits | pathway | 1.00 |
| Parkinson | associated_with | disease | 1.00 |
| Blood-Brain Barrier | therapeutic_target | pathway | 1.00 |
| Toll-Like Receptor | activates | pathway | 1.00 |
| Alzheimer | therapeutic_target | disease | 1.00 |
| Dementia | activates | disease | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| neurodegeneration | activates | process | 1.00 |
| Oxidative Stress | therapeutic_target | pathway | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Toll-Like Receptor | activates | pathway | 1.00 |
| Inflammasome | activates | pathway | 1.00 |
| Blood-Brain Barrier | activates | pathway | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| Inflammasome | activates | pathway | 1.00 |
| Synaptic Plasticity | activates | pathway | 1.00 |
| Mitophagy | activates | pathway | 1.00 |
| Mapk | activates | pathway | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| entities-complement-system | involved_in | wiki | 0.00 |
| entities-microglia-in-neurodegeneration | involved_in | wiki | 0.00 |
| PARKINSON | associated_with | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| ALZHEIMER | causes | gene | 1.00 |
| INFLAMMATION | causes | gene | 1.00 |
| TRAUMATIC BRAIN INJURY | causes | gene | 1.00 |
| Aging | activates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| PARKINSON | associated_with | gene | 1.00 |
| TAU | regulates | gene | 1.00 |
| ALZHEIMER | causes | gene | 1.00 |
| AGING | regulates | gene | 1.00 |
| APOE | regulates | gene | 1.00 |
| INFLAMMATION | biomarker_for | gene | 1.00 |
| MICROGLIA | causes | gene | 1.00 |
| NEURODEGENERATION | biomarker_for | gene | 1.00 |
| PARKINSON | activates | gene | 1.00 |
| NEURODEGENERATION | biomarker_for | gene | 1.00 |
| ALZHEIMER'S DISEASE | biomarker_for | gene | 1.00 |
| DEMENTIA | activates | gene | 1.00 |
| DEMENTIA | activates | gene | 1.00 |
| MICROGLIA | regulates | gene | 1.00 |
| NEUROINFLAMMATION | interacts_with | gene | 1.00 |
| MICROGLIA | inhibits | gene | 1.00 |
| INFLAMMATION | inhibits | gene | 1.00 |
| NEUROINFLAMMATION | inhibits | gene | 1.00 |
| MICROGLIA | inhibits | gene | 1.00 |
| INFLAMMATION | inhibits | gene | 1.00 |
| BDNF | activates | gene | 1.00 |
| MICROGLIA | interacts_with | gene | 1.00 |
| PARKINSON'S DISEASE | associated_with | gene | 1.00 |
| INFLAMMATION | causes | gene | 1.00 |
| AKT | activates | gene | 1.00 |
| APP | activates | gene | 1.00 |
| ASTROCYTES | activates | gene | 1.00 |
| ASTROCYTES | activates | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| NEUROINFLAMMATION | causes | gene | 1.00 |
| ALZHEIMER | biomarker_for | gene | 1.00 |
| TNF-Α | inhibits | gene | 1.00 |
| SIRT1 | activates | gene | 1.00 |
| NEURODEGENERATION | causes | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| PARKINSON | activates | gene | 1.00 |
| NEURODEGENERATIVE DISORDERS | activates | gene | 1.00 |
| PARKINSON'S DISEASE | associated_with | gene | 1.00 |
| TAU | regulates | gene | 1.00 |
| ASTROCYTES | regulates | gene | 1.00 |
| BRAIN INJURY | associated_with | gene | 1.00 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-28 | 17 hypotheses Top: 0.828
Alzheimer's disease | 2026-04-28 | 7 hypotheses Top: 0.670
neurodegeneration | 2026-04-28 | 7 hypotheses Top: 0.662
neurodegeneration | 2026-04-27 | 7 hypotheses Top: 0.710
neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.728
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| PGC-1α knockout analysis of PV+ interneuron maturation | validation | neurodevelopmental disorders | 0.850 | 0.00 | knockout mice | proposed | N/A |
| PV+ interneuron subtype diversification analysis | exploratory | neurodevelopmental disorders | 0.750 | 0.00 | mouse cortical PV+ interneuron | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861] | ["Han X", "Sun S", "Sun Y", "Song Q", "Z | Autophagy | 2020 | 1 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438] | Hegdekar N, Sarkar C, Bustos S, Ritzel R | Autophagy | 2023 | 0 |
| Inflammasome assembly in neurodegenerative diseases. [PMID:37633753] | Singh J, Habean ML, Panicker N | Trends in neurosciences | 2023 | 0 |
| NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pat [PMID:34877938] | Li S, Sun Y, Song M, Song Y, Fang Y, Zha | JCI insight | 2021 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Multiple Sclerosis Pathology. [PMID:29358320] | Lassmann H | Cold Spring Harbor perspective | 2018 | 0 |
| Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodeg [PMID:30381407] | Gordon R, Albornoz EA, Christie DC, Lang | Science translational medicine | 2018 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.57 · 2026-04-28
closed · Rounds: 4 · Score: 0.63 · 2026-04-28
closed · Rounds: 4 · Score: 0.72 · 2026-04-28
closed · Rounds: 4 · Score: 0.76 · 2026-04-28
closed · Rounds: 4 · Score: 0.77 · 2026-04-28
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 4 · Score: 0.46 · 2026-04-27
closed · Rounds: 4 · Score: 0.12 · 2026-04-27
closed · Rounds: 4 · Score: 0.42 · 2026-04-27
Hypotheses and analyses mentioning NEUROINFLAMMATION in their description or question text
Score: 0.703 · neurodegeneration · 2026-04-16
**Molecular Mechanism and Rationale** The pathogenesis of Parkinson's disease (PD) involves complex interactions betwee
Score: 0.680 · neurodegeneration · 2026-04-21
**Molecular Mechanism and Rationale** The molecular mechanism underlying AQP4-mediated neuroinflammation centers on the
Score: 0.665 · unknown disease · 2026-04-26
Reactive astrocytes release GFAP-positive extracellular vesicles (Astrocyte-EVs) into circulation with end-feet retracti
Score: 0.650 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The molecular foundation of this therapeutic approach centers on the dual functio
Score: 0.601 · neuroinflammation · 2026-04-15
## Mechanistic Overview STING Antagonism Prevents Acute-to-Chronic Neuroinflammation Transition via Interruption of IFN-
Score: 0.587 · alzheimers · 2026-04-04
# Cardiovascular-Neuroinflammation Crosstalk Interruption: Targeting Shared Inflammatory Mediators in Neurodegeneratio
Score: 0.580 · neuroinflammation · 2026-04-21
## Mechanistic Overview Astrocyte cGAS/STING Activation Converts Protective into Destructive Neuroinflammation starts fr
Score: 0.580 · neurodegeneration · 2026-04-21
**Molecular Mechanism and Rationale** The proposed mechanism centers on a complex inflammatory cascade initiated by APO
Score: 0.571 · neuroinflammation · 2026-04-20
**Molecular Mechanism and Rationale** The PINK1/PARK2 mitophagy pathway represents a critical quality control mechanism
Score: 0.550 · neurodegeneration · 2026-04-25
BET Bromodomain Inhibition for Neuroinflammation Suppression
Score: 0.532 · translational-neuroscience · 2026-04-12
## Mechanistic Overview Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interface Biomarker sta
Score: 0.520 · alzheimers · 2026-04-28
Using downstream glial and amyloid/tau biomarkers (plasma p-tau217, GFAP, NfL, amyloid PET, cytokine panels, TSPO PET, m
Score: 0.510 · neurodegeneration · 2026-04-29
ALS astrocytes may acquire p16/p21-positive senescence-like states and release SASP factors that activate microglia and
Score: 0.510 · lipidomics · 2026-04-25
Astrocyte-Specific DGAT1 Inhibition to Prevent Lipid Droplet-Induced Neuroinflammation